This report analyzes nationally representative data to examine inpatient services provided to persons with schizophrenia. 
Schizophrenia is a common disorder, with a 6-month prevalence of about 1 percent of the population (Regier et al. 1988 ). In 1986 .2 percent of admissions to specialty mental health inpatient units and 37.8 percent of those under care were diagnosed as having schizophrenia . Care for patients with severe and persistent mental illness (many of whom have schizophrenia) accounts for the use of 43 percent of mental health resources (Goldman and Frank 1985; Sharfstein et al. 1993) . In spite of the clinical and economic importance of this group of patients, however, there are few nationally representative data on which to base service planning and health policy formulation.
Some national surveys, such as the National Hospital Discharge Survey of general hospitals (Olfson 1991) , report data on patients with schizophrenia from a single type of facility. Other large surveys cover multiple facility types but were done at a single point in time, such as the National Mental Health Facilities Study (Dorwart et al. 1991) . The only source of data on inpatient services delivered to persons with schizophrenia that is nationally representative, is done at several points in time, and covers multiple facility types is the National Institute of Mental Health (NIMH) Patient Sample Surveys.
The NIMH Patient Sample Surveys (which are now conducted by the Substance Abuse and Mental Health Services Administration, or SAMHSA) have been used in the past largely by the government to report basic statistics to the field (Rosenstein and Milazzo-Sayre 1981; Taube and Barrett 1985; Manderscheid and Barrett 1987; Rosenstein et al. 1989; Sonnenschein 1990, 1992) . However, there has been lit-76 SCHIZOPHRENIA BULLETIN tie use of these data to describe services for hospitalized patients with schizophrenia in a more detailed way, although a few examples do exist (Wolfe et al. 1989 ; Thompson et al. 1993) . The purpose of this article is to analyze the NIMH/SAMHSA data to provide a picture of persons with schizophrenia who are admitted to inpatient care in various hospital types, and to test several hypotheses concerning this population.
We hypothesize that given the growth in noninpatient resources over the study period (Thompson et al. 1982; Manderscheid and Sonnenschein 1992) , the rate of inpatient admissions for schizophrenia will have decreased. Second, given the increase in private inpatient facilities (Manderscheid and Sonnenschein 1992) , we expect that these facilities will serve an increasing proportion of patients with schizophrenia. Third, owing to increasing restrictions on private insurance for mental disorders (e.g., Hustead et al. 1985; Brady et al. 1986; Sharfstein et al. 1993) , we expect that there will be an increase in use of public sources of reimbursement.
Methods
We analyzed the NIMH/SAMHSA Patient Sample Surveys, which are a part of the NIMH (now SAMHSA) National Reporting Program (Redick et al. 1983 (Redick et al. ), for 1970 (Redick et al. , 1975 (Redick et al. , 1980 (Redick et al. , and 1986 . A random sample of patients is chosen from a representative sample of all psychiatric inpatient facilities in the United States. No facility is obligated to provide data, but the overall response rate is at least 75 percent and is often in the range of 85 to 90 percent. The surveys have been essentially similar from year to year, allowing for trend analyses.
Our analyses include specialty psychiatric unit beds in public general hospitals (PubGH) (which are owned by governmental entities), private general hospitals (PrivGH), and (in 1980) multiservice general hospitals (MultiGH). General hospital "swing" beds are not included. Also included are private psychiatric hospitals (PPH) (freestanding hospitals devoted entirely to the treatment of psychiatric disorders), and State and county mental hospitals (SCMH).
MultiGH is a designation used by NIMH only in 1980 to describe general hospitals having inpatient, outpatient, and one other type of service, such as day treatment. These hospitals were distributed into the other general hospital categories in 1986 and therefore are included in our tables for 1980 to make the data comparable with 1986. These hospitals were part of the NIMH community mental health center (CMHC) inventories in 1970 and 1975 and so were not included in the Patient Sample Surveys in these years. The 1970 and 1975 general hospital data, therefore, are not completely compatible with later data. We have estimated the number of cases missed, using NIMH publications on CMHCs, and these estimates are found in the "Limitations of the Data" section and in a footnote to table 1. We do not report trend data for Department of Veterans Affairs (VA) hospitals, since we have data from these hospital types for only 2 years (1980 and 1986) , or for freestanding CMHC inpatient units, for which only 1986 data are available.
The data presented here are weighted to reflect national estimates (n = 860,637 weighted cases over the study period). Further details on the design of these surveys are available in NIMH and SAMHSA publications (Rosenstein and Milazzo-Sayre 1981; Manderscheid and Barrett 1987; Sonnenschein 1990, 1992) .
"Schizophrenia" for our purposes includes catatonic, disorganized, paranoid, undifferentiated, and residual schizophrenia. We exclude schizophreniform disorder (by definition not a chronic illness) and schizoaffective disorder (which might be confused with affective disorders). Diagnoses before 1980 were made according to DSM-II (American Psychiatric Association 1968); DSM-III (American Psychiatric Association 1980) was used in 1980 and 1986. We studied patients 18 years of age and older, since only 2 percent of patients with schizophrenia admitted to inpatient care are under the age of 18. In addition, schizophrenia in childhood may represent a different syndrome than that occurring in adulthood.
We use the category "no-pay" as a proxy for medical indigence, since these patients were not covered by insurance at the time of study. The category "self-pay" in State hospitals very likely includes many low-fee patients, who may well be medically indigent, although this designation may or may not represent low-fee patients in other hospital types. "Other public funds" includes a variety of payment sources, all of which are government entities, including State medical assistance, social service funds, and payments from forensic and substance abuse facilities. Some hospitals may also include writeoffs in this category, instead of in the no-pay category. The racial/ethnic groups included are white (Caucasian) and African-American. Hispanics, Asians, and Native Americans are excluded because of their relatively low numbers in inpatient care (a total of 6% of admissions of patients with schizophrenia over all years and all hospital types, too small a group for meaningful analysis). Grouping these individuals with African-Americans into a nonwhite category creates confusion as to group membership.
To examine trends, we ran a series of two-stage hierarchical multiple regression models with admissions of persons with schizophrenia in each survey year as the dependent variable. The stage 1 regression models included race, gender, age, and primary source of payment. In stage 2, two-level interactions were added. The multivariate analysis also served as a variable selection mechanism. Variables that were significant in the regression analyses were then used to perform cross-tabulations.
For cross-tabulations we use SUDAAN software (Shah 1989) where technically possible. This is the software used by SAMHSA to analyze these surveys. Most statistical software, such as the Statistical Analysis System (SAS; SAS Institute, Inc., 1985) treats all data as though they were collected using simple random sampling. However, these data were collected by means of a complex sampling design (Yates 1981) rather than simple random sampling. SUDAAN uses the Taylor method of variance approximation (Woodruff 1971) to adjust for complex sampling design, allowing standard errors of the estimates to be more accurately calculated. (This leads to a more conservative standard error than does SAS.) SUDAAN and SAS produce the same counts of cases.
In cross-tabular analyses, we correct for multiple comparisons by taking p < 0.01 as our level of significance to protect against Type I error. We also report statistics with p < 0.05 to inform the reader of results with this less conservative significance level.
Multivariate analyses are done with SAS, with p < 0.01 taken as statistically significant. This departure from the usual p < 0.05 level represents an overall correction for design effect. (It was not technically possible to use SUDAAN for these analyses because of survey design differences between 1986 and previous years.)
Unless otherwise noted, comparisons are from 1970 to 1986. Tests for statistical significance were done with the Z-test for differences between proportions. The U.S. civilian resident population over the age of 18 was used to calculate rates per 100,000.
Results
The proportion of patients admitted to all hospital types combined The schizophrenia admissions rate decreased from 130 to 118 for whites and increased from 470 to 557 for African-Americans. The increase for African-Americans was due entirely to increased admissions of African-American males, whose rate increased from 599 to 724. The admission rate decreased for African-American females.
Between 1970 and 1986 the proportion of patients with schizophrenia who were admitted to PubGH decreased from 28.3 percent to 11.5 percent (Z = 6.76, p < 0.0001) (table 1). Admissions for schizophrenia to PrivGH increased from 16.3 to 37.6 percent (Z = 4.87, p < 0.0001). As noted below, changes in numbers of these facilities may explain some of this shift. The proportion of admissions to PPH and SCMH did not change.
To more closely examine trends and to select variables for crosstabular analyses, we ran a series of two-stage hierarchical multiple regression models (one for each hospital type) with admissions of persons with schizophrenia in the year of survey as the dependent variable. The stage 1 regression models accounted for between 8 and 24 percent of the variation, depending on hospital type. Race and at least one aspect of payment source were significant in each model; gender was significant in all but one model (PubGH); age was not significant in any model.
In stage 2, the race by payment source interaction was significant in all models except PrivGH and the gender by payment source interaction was significant only in PPH. (These interactions indicate that African-American individuals with particular payment sources and males with particular payment sources were important in the explanatory models.) The interaction terms increased the amount of variation explained by the models to between 12 and 26 percent.
Gender and Race. Variables that were significant in the regression analyses were used to perform cross-tabulations. The proportion of patients with schizophrenia who were male increased in all hospital types except PubGH (Z = 2.60, p < 0.01 for PrivGH; Z = 4.30, p < 0.0001 for PPH; Z = 3.96, p < 0.0001 for SCMH) ( .) The proportion of patients using private insurance did not change in PPH (Z = 2.24, p < 0.05) or in PubGH. No-pay patients were common only in SCMH but did not increase in these hospitals over the study period (Z = 2.47, p < 0.05). The use of Medicare increased in both general hospital types (Z = 5.36, p < 0.0001 for PubGH; Z = 5.82, p < 0.0001 for PrivGH), but not in other hospital types (Z = 2.27, p < 0.05 for PPH; Z = 2.49, p < 0.05 for SCMH). After 1970, the great majority of patients on Medicare were not elderly; during the study period, 85 percent were under 65 years of age, suggesting that they were recipients of Social Security Disability Income.
Medicaid use increased in PrivGH (Z = 4.62, p < 0.0001). The apparent decrease in PubGH was not statistically significant. Use of other public funds as the primary source of payment decreased from 30.5 to 11.3 percent (Z = 2.68, p < 0.01) in SCMH. It is not clear what was reported in the other public funds category in PPH in 1986 (Z = 2.32, p < 0.05).
Data on payment source by race are not shown in a table. Self-pay has been a much more significant payment source for white than for African-American patients. Its use by whites decreased in all hospital types except PubGH, in which there was a modest increase. On the other hand, no-pay has been important over the study period for both white and AfricanAmerican patients in PubGH and SCMH. Use of the no-pay category decreased for white patients but increased over the study period for African-American patients, particularly for African-American males in SCMH (from 7,037 to 27,224 cases).
The use of Medicare increased in all race/gender groups except for African-American females. The decrease in the use of private insurance was largely restricted to white patients; all AfricanAmerican patients with schizophrenia (except males in SCMH) used private insurance more.
Discussion
Demographic Changes. With regard to our first hypothesis, the rate of inpatient admissions for schizophrenia did decrease overall and in all hospital types except PrivGH. (If MultiGH had been included in the 1970 figure, the decrease would have been even greater.) Subgroup analysis showed a decrease in admission rates for all groups except African-American males, whose rate increased greatly. The largest numerical increase was in SCMH. This increase is discussed in previous work ). The demographic changes might be explained in several ways. First, it is recognized that AfricanAmericans are diagnosed as having schizophrenia much more often than whites (Neighbors 1984) in spite of similar rates in community surveys (Robins et al. 1984) . However, if an exacerbation in this labeling phenomenon were the reason for the increase in the rate of African-American admissions with schizophrenia, we would expect an increase in the rate for AfricanAmericans of both sexes, which did not occur.
A related possibility is the misidentification of drug-induced psychosis in African-American males as schizophrenia. Lehman and colleagues (1993) have shown that there are indeed a large percentage of "dually diagnosed" individuals who have substance-induced psychoses rather than schizophrenia. To examine this possibility further, secondary diagnoses would be needed, since many psychiatric facilities would probably list schizophrenia as the first diagnosis even if substance abuse was the major problem.
Another possible reason for the 
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demographic changes might be that noninpatient care, which has grown over the study period (Thompson et al. 1982; Manderscheid and Sonnenschein 1992) , is increasingly being used selectively for women of both races and for white males. However, this possibility is not confirmed by the 1975 and 1986 NIMH Patient Sample Survey data for outpatient facilities, which show the same gender/race pattern as inpatient settings.
Alternatively, since a large proportion of African-American patients come from urban areas, the increase in admissions of AfricanAmerican males may be related to a general deterioration in urban society. Over the last two decades there has been an outmigration of jobs from urban areas, particularly in well-paying unskilled jobs (Kasarda 1988) . One result has been an increase in long-term unemployment among AfricanAmerican males (Wacquant and Wilson 1989 ) and a related increase in crime and drug use by this population. The result has apparently been increased institutionalization of African-American males in jails (National Center on Institutions and Alternatives 1992). Increased admissions to psychiatric hospitals may also represent an attempt to deal with this population when behaviors are present that are seen as psychotic. Such admissions may also be the result of a general community perception of African-American males as dangerous and in need of institutionalization.
The possibility must be considered that African-American males selectively have a high and increasing community prevalence of schizophrenia, which is affecting inpatient service use. It could be argued that even in large community epidemiologic surveys (Robins et al. 1984; Regier et al. 1988 ), so few cases of schizophrenia are found that this gender/ race difference in prevalence is not being seen. Further research is necessary to examine carefully whether African-American males are being overdiagnosed with schizophrenia or whether there is a true difference in community prevalence. (These data, of course, represent treated [inpatient] prevalence, not community prevalence.)
It should also be noted that the demographic structure of the population changed over the study period, which might affect incident cases. The population shifts do not fit the pattern of our findings, however. There was a population decrease in the 15-to 19-year-old group and an increase in the 20-to 24-year-old group for white males and females. For AfricanAmerican males and females, the population increased in each age group over the study period.
Finally, there was a change in the diagnostic system over the study period, which may have changed the number of patients diagnosed as having schizophrenia. Such a change might have differentially affected African-American males. This possibility requires further scrutiny, but the overall patterns of change do not support it, since there was no abrupt change in the data in 1980 when DSM-HI wa.i introduced. The change in diagnostic systems is discussed further below.
Shift to Private Facilities. Our second hypothesis, that private facilities will serve an increasing proportion of patients with schizophrenia, was borne out in part. There was a shift away from 82 SCHIZOPHRENIA BULLETIN PubGH and toward PrivGH. A large increase in the numbers of PrivGH facilities (from 533 to 1,019) between 1970 and 1983-84 (when sampling was done for the 1986 survey) may explain some of the shift. However, the number of PubGH also increased (from 157 to 240). There were 122 MultiGH in 1980, which were distributed into the PubGH and PrivGH categories in 1983-84. This accounts for some of the increase in numbers of PubGH and PrivGH. Also, the number of PPH increased (from 140 to 210) without a concomitant rise in the rate of admissions with schizophrenia, and the number of SCMH decreased only slightly (from 295 to 280), while the decrease in the rate of these admissions to SCMH was much more dramatic.
It should be noted that we do not have trend data for several inpatient facility types. This lack is discussed below in the "Limitations of the Data" section.
Sources of Payment. Our third hypothesis, that there will be an increased use of public sources of payment, is also partially confirmed. There was a decrease in the use of private insurance in PrivGH and SCMH, and the use of Medicare increased. The use of Medicaid shifted dramatically to PrivGH. (A more indepth examination of changes in Medicaid would need to take into account restrictions on Medicaid for patients in psychiatric hospitals [Taube and Goldman 1989; Sharfstein et al. 1993] .)
The decrease in private insurance reimbursement, especially in private facilities, is not surprising. There are more restrictions on private insurance for psychiatric care, including those due to managed care (Tischler 1990) , and it appears that individuals with schizophrenia have been especially hard hit as insurance companies try to avoid coverage for chronic illnesses of all kinds, particularly for the severely mentally ill.
The increased use of Medicaid dollars by PrivGH appears to represent a new "market" sought out by PrivGH as private sources of reimbursement diminish. There was also an increase in Medicaid use by PPH patients in 1975 and 1980, but this increase seems to have ended as of the 1986 survey. Possibly offsetting this, however, was an increase in PPH in the use of other government funds, largely for African-American males. In summary, public dollars are apparently being used to offset the loss of private insurance dollars in several hospital types.
One factor we could not examine rigorously is the possibility of a cohort effect over the study period, since NIMH chose a new sample of facilities and patients each year. Also, no individual identifiers are present in the data. It may be that the insurance changes noted do represent a cohort effect, since aging of the population with schizophrenia may be accompanied by an exhaustion of private insurance or a loss of coverage secondary to downward drift. The data at hand showed no obvious cohort effect in the age of admissions in each year. Such an effect cannot be ruled out, however.
Limitations of the Data. In addition to the caveats discussed above, there are several other important limitations of these data. First, as noted above, these data represent only inpatient services delivered to people with schizophrenia. There are many important portions of the service system that are not included, and even some parts of the inpatient service system are missing. These data do not include "swing" beds in general hospitals for any year. Nor do we have trend data for freestanding community mental health center inpatient units, although we do know that these facilities (labeled multiservice facilities by SAMHSA in 1986) accounted for 18,907 admissions for schizophrenia in 1986.
Also, as noted above, MultiGH data are not included in the 1970 and 1975 figures, although we estimate that these facilities admitted 5,900 patients with schizophrenia in 1970 and 8,320 in 1975. (If these data were to be added to total inpatient admissions for schizophrenia in 1970 and 1975, they would represent a small percentage of such admissions-2.7% in 1970 and 4.2% in 1975.) VA hospitals were not included in our trend analyses, and it may be that changes in admissions to these hospitals influenced admissions to the other facilities studied. There were 40,985 admissions to VA hospitals for schizophrenia in 1980 (31 per 100,000) and 42,294 in 1986 (24 per 100,000). The number of VA hospitals changed little, from 121 to 125 over this period.
We conclude that although VA hospitals admit a significant number of persons with schizophrenia, changes in the 1980s follow the previously noted trend of a shift away from the public sector. It is possible, however, that if data on changes in admissions to these hospitals in the 1970s had been available, we might have been led to different conclusions.
Second, changes in community prevalence and incidence rates over the study period could have affected the number of patients with schizophrenia admitted to inpatient units and therefore could have affected our findings. However, it is unlikely that these community rates have changed over the study period ).
Third, changes in diagnostic practice over the study period could have influenced these results. Because there were no diagnostic criteria in DSM-1I, there may have been a less stringent definition of schizophrenia in 1970 and 1975 , although Olfson (1991 has argued that the change in diagnostic systems did not move large numbers of patients into or out of the broad category of schizophrenia. Indeed, these data on rates of admission are congruent with the occurrence of such a change in diagnostic practice (toward a more stringent definition of schizophrenia). However, there are different patterns in rates between various facility types, and it is not obvious why effects of the change from DSM-U to DSM-U1 would have been selective. Fourth, many changes in the service system have taken place since 1970. This means that the interpretation of data on one portion of the system (inpatient services) is not straightforward. Surveys of the entire service system are very much needed. Even with regard to the portion of the service system we do report on here, it is important not to overinterpret these data. Survey-based research on services highlights trends but seldom yields detailed or definitive answers. Related to this point, these data on services should not be misinterpreted as reflecting community prevalence.
Finally, changes in accessibility of services are also an important determinant of services use, but aside from the data on reimbursement this data set contains no information on accessibility. Changes in accessibility that affect particular groups (racial, socioeconomic, etc.) would be especially important to study in detail.
Conclusion
Particularly in light of the changes reported here for the 1970s and 1980s, further research is needed to follow trends in delivery of services to patients with schizophrenia and trends in reimbursement for those services into the 1990s. For example, anecdotal evidence suggests that the trends reported in funding may have accelerated since 1986. It would be important to know whether or not this is the case. Also, in future research a more complete and detailed picture must be assembled than was possible with these data. Such a picture must include inpatient psychiatric care, noninpatient care, and care in other sectors, such as the forensic and drug treatment systems. The results of such work will serve as an important baseline against which to evaluate the effects of national health care reform (Sharfstein et al. 1993 ) on the availability of services to patients with schizophrenia.
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